BFLY Butterfly Network, Inc.
X-Ray Apparatus & Tubes & Related Irradiation Apparatus · NYSE · SEC CIK 1804176 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY39.4%
TTM net income YoY32.8%
TTM EPS YoY36.4%
Revenue 3-yr CAGR21.7%
Net income 3-yr CAGR—
Margins
Gross margin70.3%
Operating margin-46.9%
Net margin-43.6%
FCF margin-22.4%
EBITDA margin—
Returns
ROE-27.7%
ROA-18.6%
ROIC (approx.)-75.1%
Asset turnover0.43x
Leverage & solvency
Liabilities / assets36.0%
Debt / equity0.00x
Current ratio3.58x
Interest coverage-46.82x
Cash quality & payout
Operating cash flow / net income0.44x
Accruals ratio-10.5%
Payout ratio—
Capex / revenue3.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $97.61M | $82.06M |
| Cost of revenue | $51.88M | $33.23M |
| Gross profit | $45.73M | $48.83M |
| R&D expense | $36.26M | $37.80M |
| SG&A expense | $39.23M | $39.81M |
| Operating income | -$86.42M | -$74.41M |
| Interest expense | $1.49M | $1.26M |
| Pretax income | -$76.95M | -$72.52M |
| Income tax | $110,000 | -$32,000 |
| Net income | -$77.06M | -$72.49M |
| EBITDA | -$79.72M | -$65.51M |
| EPS (basic) | -0.31 | -0.34 |
| EPS (diluted) | -0.31 | -0.34 |
| Dividends declared per share | 0.00 | 0.00 |
| Weighted avg. shares (diluted) | 247.12M | 211.68M |
| Balance sheet | ||
| Cash & equivalents | $150.49M | $92.79M |
| Receivables | $26.74M | $20.79M |
| Inventory | $61.39M | $70.79M |
| Current assets | $249.10M | $192.61M |
| PP&E, net | $16.59M | $19.52M |
| Intangibles | $7.52M | $8.92M |
| Total assets | $296.53M | $256.08M |
| Current liabilities | $65.12M | $48.22M |
| Total liabilities | $100.55M | $87.25M |
| Shareholders' equity | $195.98M | $168.83M |
| Cash flow statement | ||
| Operating cash flow | -$12.70M | -$41.71M |
| Capital expenditure | $3.35M | $2.69M |
| Free cash flow | -$16.05M | -$44.40M |
| Investing cash flow | -$3.35M | -$2.66M |
| Financing cash flow | $77.76M | -$1.50M |
| Depreciation & amortization | $6.70M | $8.90M |
| Stock-based compensation | $23.43M | $21.03M |
Free plan shows the latest 2 periods; Pro shows all 7 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.